“The added capacity will greatly benefit the global market and strengthen supply security for major pharmaceutical companies and contract manufacturing organizations,” said Andreas Reisse, Executive Vice President of SCHOTT’s Pharma business unit. 

 

The drug containment and delivery solution is an integral part of every medication. Typically, a new drug enters the market in a vial and a single-use syringe is used to extract and administer it. In the mid-to-long term, these drugs may be stored in syringes that are prefilled with the medication. This simplifies the injection process for healthcare workers and increases dosing accuracy for the patient, as the syringe is already readily prepared. 

 

“High-quality prefillable syringes are designed to ease the administration process, ultimately enhancing patient safety,” said Christian Helbig, Head of Glass Syringes at SCHOTT’s Pharma business unit. “Our borosilicate glass PFS are used to safely store a wide range of drugs, including vaccines and biologics.”
 

SCHOTT’s Hungarian site in Lukácsháza currently plays an important role in supplying the global industry with drug containment systems and provides enough space for further capacity expansions.